Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 408
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01259856 | Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) | ||
| NCT00407186 | Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) | ||
| NCT04341181 | ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling | ||
| NCT01326559 | Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) | ||
| NCT00400738 | The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients | ||
| NCT01226771 | Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 | ||
| NCT03654833 | Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma | ||
| NCT02558816 | A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients | ||
| NCT03449914 | The GOLD Study: G8 in OLDer Patients | ||
| NCT00193609 | Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site | ||
| NCT03911219 | Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy | ||
| NCT00944684 | High Dose Ribavirin in the Treatment of Chronic Hepatitis C | ||
| NCT05733611 | RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC | ||
| NCT01249638 | Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC | ||
| NCT05057234 | PRecision Oncology Evidence Development in Cancer Treatment - Liquid | ||
| NCT04939662 | Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects | ||
| NCT00198146 | Prevention of Diabetes Progression Trial (PDPT) | ||
| NCT05050214 | Obinutuzumab in Primary MN | ||
| NCT04335071 | Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) | ||
| NCT02407080 | Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia | ||
| NCT04148066 | ctDNA Guided Treatment of Early Resistance to Targeted Treatment | ||
| NCT00079053 | Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT01450137 | Tocilizumab for Patients With Giant Cell Arteritis | ||
| NCT01423695 | Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | ||
| NCT00264290 | Valganciclovir to Reduce T Cell Activation in HIV Infection | ||
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors | ||
| NCT00405860 | CellCept in p-ANCA Vasculitis | ||
| NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | ||
| NCT00275535 | The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients | ||
| NCT03224208 | Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients | ||
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | ||
| NCT03848052 | Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) | ||
| NCT04920981 | Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC | ||
| NCT03831490 | Study for Improving Maternal, Pregnancy and Child Outcomes | ||
| NCT01368848 | Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) | ||
| NCT04611867 | Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) | ||
| NCT01472029 | Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach | ||
| NCT00095901 | Capecitabine For Nasopharyngeal Cancer | ||
| NCT03275311 | Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | ||
| NCT05919342 | Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF" | ||
| NCT00730769 | Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients | ||
| NCT00275665 | The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection. | ||
| NCT01457144 | Study of Mantle Cell Lymphoma Treatment by RiBVD | ||
| NCT00201825 | A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients | ||
| NCT01458730 | Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma | ||
| NCT03915678 | Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors | ||
| NCT03784599 | T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC | ||
| NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | ||
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer | ||
| NCT00440167 | Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine |
